Carolyn Morales, MD
Obstetrics & Gynecology · Silver Spring, MDNPI 1811984115
Payments from drug & device makers
Across 113 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580
- Exeltis, USA Inc.$345
- Daiichi Sankyo Inc.$248
- Therapeuticsmd, Inc.$154
- Pfizer$135
- Aspira Women's Health Inc$108
- plus $781 from 17 others
What the payments were for
- Food & beverage$2,34099%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $580 |
| Exeltis, USA Inc. | 18 | $345 |
| Daiichi Sankyo Inc. | 9 | $248 |
| Therapeuticsmd, Inc. | 3 | $154 |
| Pfizer | 10 | $135 |
| Aspira Women's Health Inc | 2 | $108 |
| Coopersurgical, Inc. | 6 | $88 |
| Astellas Pharma US Inc | 4 | $85 |
| Renovia Inc | 1 | $73 |
| Amgen | 4 | $71 |
| Medtronic | 1 | $64 |
| Avion Pharmaceuticals | 4 | $57 |
| Exact Sciences | 2 | $43 |
| Mylan Pharmaceuticals Inc. | 3 | $43 |
| Bayer | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Merck | 2 | $34 |
| Scynexis, Inc. | 2 | $32 |
| Millicent US Inc | 2 | $29 |
| Roche Diagnostics Corporation | 1 | $24 |
| Myovant Sciences Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIJUVA$120
- INJECTAFER$104
How this compares
$2,352 in reported general payments places this provider in the 75th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 49 | $3,298 |
| YuvafemEstradiol | 25 | $3,284 |
| ValacyclovirValacyclovir Hcl | 16 | $613 |
| Terconazole | 21 | $580 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $574 |
| Metronidazole | 15 | $389 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 16 | $275 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $138 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Silver Spring
- Otis StittSilver Spring$641K
- Sweta PatelSilver Spring$24K
- Ifeyinwa StittSilver Spring$19K
- Darryn BandSilver Spring$8K
- Tamara CoatesSilver Spring$6K
- Ashleigh BouchelionSilver Spring$6K
- Colleen McCormickBaltimore$1.9M
- Jenell ColemanBaltimore$1.2M
- Issam DayaTowson$940K
- Danielle ShillerBaltimore$473K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.